Alicanto is a technology company.
Alicanto has raised $4.0M across 1 funding round.
Alicanto has raised $4.0M in total across 1 funding round.
Alicanto Cloud is a secure online collaboration and learning platform developed for healthcare professionals, enabling streamlined clinical consultations, group discussions, education, and knowledge sharing across institutions and countries.[1][3] It combines tools like document sharing, web conferencing, online courses, assessments, and secure clinical case reviews, serving clinicians in fields such as cancer, pediatrics, and diabetes at organizations like Beth Israel Deaconess Medical Center (BIDMC), Dana-Farber Cancer Institute, and Joslin Diabetes Center.[1][3] The platform solves challenges in global health collaboration by facilitating synchronous and asynchronous communication, standardizing care guidelines, virtual tumor boards, and capacity building, especially amid restrictions like pandemics; it has supported over 600 virtual tumor board discussions across 13 hospitals and global networks in sub-Saharan Africa and diabetes education.[3] Its growth stems from scalability on AWS, handling 30,000+ users without performance issues, and high security standards including encryption and 2FA.[1]
Alicanto Cloud originated in 2015 at BIDMC's Division of Clinical Informatics in the Department of Medicine, spearheaded by Yuri Quintana, a key developer with expertise in clinical informatics and global health.[1][3] Quintana collaborated with colleagues from BIDMC, Joslin Diabetes Center, and Dana-Farber Cancer Institute to address gaps in cross-institutional communication and education, particularly for complex clinical cases and global health challenges.[3] The idea emerged from the need for systematic stakeholder collaboration worldwide, accelerated by pandemic-related travel restrictions, leading to its implementation as a multifaceted platform for learning health systems.[3] Early traction included adoption for cancer collaborations at BIDMC (connecting 13 hospitals), diabetes networks at Joslin, and cancer training in sub-Saharan Africa at Dana-Farber, marking pivotal moments in evidence synthesis and capacity building.[3]
Alicanto rides the trend of digital learning health systems, leveraging cloud collaboration to bridge global expertise gaps in healthcare amid rising telemedicine and remote training demands post-pandemic.[3] Its timing aligns with market forces like travel restrictions and uneven expert distribution, enabling cross-border knowledge management in oncology, diabetes, and pediatrics without physical meetings.[3] By accelerating evidence-to-dissemination workflows—such as standardizing guidelines and virtual tumor boards—Alicanto influences the ecosystem, fostering capacity building in underserved regions like sub-Saharan Africa and enhancing institutional networks at U.S. leaders like BIDMC.[3] This positions it as a key enabler in health tech's shift toward scalable, secure platforms for collaborative care innovation.[1][3]
Alicanto Cloud stands out as a mature, battle-tested platform poised for expanded adoption in global health networks, with potential growth in AI-enhanced case reviews or broader EHR integrations. Trends like rising chronic disease burdens and hybrid care models will amplify its role, especially as health systems prioritize secure, scalable collaboration tools. Its influence may evolve by powering more international consortia, solidifying its niche in accelerating learning health systems from Quintana's 2015 vision to worldwide impact.[1][3]
Alicanto has raised $4.0M in total across 1 funding round.
Alicanto's investors include Battery Ventures, Greylock, IVP, Sapphire Ventures, Sequoia Capital, Sutter Hill Ventures, Wing Venture Capital.
Alicanto has raised $4.0M across 1 funding round. Most recently, it raised $4.0M Series A in April 2012.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2012 | $4.0M Series A | Battery Ventures, Greylock, IVP, Sapphire Ventures, Sequoia Capital, Sutter Hill Ventures, Wing Venture Capital |